The Procet Facet Allograft Implant system has a dual-hemispherical shape that limits motion while providing distraction; and unlike other products currently available, it is designed to remain stable in the joint, to increase the potential for fusion, according to the company. This procedure provides surgeons a percutaneous, less-invasive, early stage treatment, which is particularly beneficial to elderly patients for whom more extensive open surgery may present too great a surgical risk.
"The launch of the Procet system is an example of Amedica's commitment to further expand our line of innovative facet products to support our surgeon customers and the patients they treat," Eric K. Olson, president and CEO. "Procet, in addition to our other facet products, showcases our company's strength in developing state-of-the-art, minimally invasive medical products."
Olsen said the product launch is consistent with the company's strategy to increase sales of proprietary, IP-backed products, "which should drive improved gross margins and profitability."
The Procet Facet Allograft Implants add to Amedica's existing Facet Fixation System portfolio which includes the Javelin MIS Facet Screw System and FacetGun Max System.Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized Orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and are sold in ten countries.